Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Patten

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Biorxiv : the Preprint Server for Biology|October 31, 2023
Design of universal Ebola virus vaccine candidates <i>via</i> immunofocusingDuo Xu, Abigail E Powell, Ashley Utz, et al.
AIDS (London, England)|April 1, 1994
The pattern of diagnosed HIV infection in Australia, 1984-1992A M McDonald, N Crofts, C E Blumer, et al.
Arxiv|June 19, 2020
Network Medicine Framework for Identifying Drug Repurposing Opportunities for COVID-19Deisy Morselli Gysi, Ítalo Do Valle, Marinka Zitnik, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 28, 2021
Network medicine framework for identifying drug-repurposing opportunities for COVID-19Deisy Morselli Gysi, Ítalo do Valle, Marinka Zitnik, et al.
The Medical Journal of Australia|January 4, 1993
The acquired immunodeficiency syndrome in Australia: incidence 1982-1991J Kaldor, A M McDonald, C E Blumer, et al.
Virology|June 11, 2022
Adipocytes are susceptible to Ebola Virus infectionFrancoise A Gourronc, Michael R Rebagliati, Breanna Kramer-Riesberg, et al.
Iscience|June 10, 2025
Soluble CD4 inhibits Ebola virus infection by targeting endosomal receptor-binding siteLeah Liu Wang, Patrick Keiser, Derek Yang, et al.
The Journal of Biological Chemistry|July 20, 2001
Alternative splicing determines the function of CYP4F3 by switching substrate specificityP Christmas, J P Jones, C J Patten, et al.
Journal of Medicinal Chemistry|August 22, 2024
N-Substituted Pyrrole-Based Heterocycles as Broad-Spectrum Filoviral Entry InhibitorsDestiny Durante, Ryan Bott, Laura Cooper, et al.
Antiviral Research|August 30, 2022
Brequinar and dipyridamole in combination exhibits synergistic antiviral activity against SARS-CoV-2 in vitro: Rationale for a host-acting antiviral treatment strategy for COVID-19James F Demarest, Maryline Kienle, RuthMabel Boytz, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Biorxiv : the Preprint Server for Biology|October 31, 2023
Design of universal Ebola virus vaccine candidates <i>via</i> immunofocusingDuo Xu, Abigail E Powell, Ashley Utz, et al.
AIDS (London, England)|April 1, 1994
The pattern of diagnosed HIV infection in Australia, 1984-1992A M McDonald, N Crofts, C E Blumer, et al.
Arxiv|June 19, 2020
Network Medicine Framework for Identifying Drug Repurposing Opportunities for COVID-19Deisy Morselli Gysi, Ítalo Do Valle, Marinka Zitnik, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 28, 2021
Network medicine framework for identifying drug-repurposing opportunities for COVID-19Deisy Morselli Gysi, Ítalo do Valle, Marinka Zitnik, et al.
The Medical Journal of Australia|January 4, 1993
The acquired immunodeficiency syndrome in Australia: incidence 1982-1991J Kaldor, A M McDonald, C E Blumer, et al.
Virology|June 11, 2022
Adipocytes are susceptible to Ebola Virus infectionFrancoise A Gourronc, Michael R Rebagliati, Breanna Kramer-Riesberg, et al.
Iscience|June 10, 2025
Soluble CD4 inhibits Ebola virus infection by targeting endosomal receptor-binding siteLeah Liu Wang, Patrick Keiser, Derek Yang, et al.
The Journal of Biological Chemistry|July 20, 2001
Alternative splicing determines the function of CYP4F3 by switching substrate specificityP Christmas, J P Jones, C J Patten, et al.
Journal of Medicinal Chemistry|August 22, 2024
N-Substituted Pyrrole-Based Heterocycles as Broad-Spectrum Filoviral Entry InhibitorsDestiny Durante, Ryan Bott, Laura Cooper, et al.
Antiviral Research|August 30, 2022
Brequinar and dipyridamole in combination exhibits synergistic antiviral activity against SARS-CoV-2 in vitro: Rationale for a host-acting antiviral treatment strategy for COVID-19James F Demarest, Maryline Kienle, RuthMabel Boytz, et al.
Pageof 9